Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T08:42:50.768Z Has data issue: false hasContentIssue false
  • English
  • Français

Who Is Leading This Dance? Understanding the Spread of Escherichia coli Sequence Type 131

Published online by Cambridge University Press:  02 January 2015

Benjamin A. Rogers  and
Yohei Doi
Benjamin A. Rogers
Affiliation:
University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia
Yohei Doi*
Affiliation:
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
*
Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, S829 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261 (yod4@pitt.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
Infection Control & Hospital Epidemiology , Volume 34 , Issue 4 , April 2013 , pp. 370 - 372
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Datta, N, Kontomichalou, P. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature 1965;208(5007):239–241.Google Scholar
2.Mitsuhashi, S, Harada, K, Hashimoto, H, Egawa, R. Drug-resistance of enteric bacteria. 5. Drug-resistance of Escherichia coli isolated from human being. Jpn J Exp Med 1961;31:53–60.Google Scholar
3.Coque, TM, Novais, A, Carattoli, A, et al.Dissemination of donally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008;14(2):195–200.Google Scholar
4.Nicolas-Chanoine, MH, Blanco, J, Leflon-Guibout, V, et al.Intercontinental emergence of Escherichia coli clone 025:H4ST131 producing CTX-M-15. J Antimicrob Chemother 2008;61(2):273–281.Google Scholar
5.Rogers, BA, Sidjabat, HE, Paterson, DL. Escherichia coli 025b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011;66(1):1–14.CrossRefGoogle Scholar
6.Banerjee, R, Johnston, B, Lohse, C, et al.Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013;34:361–369(in this issue).CrossRefGoogle ScholarPubMed
7.Friedman, ND, Kaye, KS, Stout, JE, et al.Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137(10):791–797.Google Scholar
8.Lau, SH, Reddy, S, Cheesbrough, J, et al.Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 2008;46(3): 1076–1080.Google Scholar
9.Blanco, M, Alonso, MP, Nicolas-Chanoine, MH, et al.Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2009;63(6):1135–1141.Google Scholar
10.Brisse, S, Diancourt, L, Laouenan, C, et al.Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J Clin Microbiol 2012;50(9):2974–2981.CrossRefGoogle ScholarPubMed
11.Burke, L, Humphreys, H, Fitzgerald-Hughes, D. The revolving door between hospital and community: extended-spectrum β-lactamase-producing Escherichia coli in Dublin. J Hosp Infect 2012;81(3):192–198.Google Scholar
12.Doi, Y, Park, YS, Rivera, JI, et al.Community-associated extended-spectrum-β-Lactamase (ESBL)-producing Escherichia coli infection in the United States. Clin Infect Dis 2012.Google Scholar
13.Seybold, U, Kourbatova, EV, Johnson, JG, et al.Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42(5):647–656.Google Scholar
14.Cheng, AC, Turnidge, J, Collignon, P, Looke, D, Barton, M, Gottlieb, T. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis 2012;18(9):1453–1460.Google Scholar
15.Rogers, BA, Kennedy, KJ, Sidjabat, HE, Jones, M, Collignon, P, Paterson, DL. Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics. Eur J Clin Microbiol Infect Dis 2012;31(9):2413–2420.Google Scholar
16.Johnson, JR, Nicolas-Chanoine, MH, DebRoy, C, et al.Comparison of Escherichia coli ST 131 pulsotypes, by epidemiologic traits, 1967–2009. Emerg Infect Dis 2012;18(4):598–607.Google Scholar
17.Weissman, SJ, Johnson, JR, Tchesnokova, V, et al.High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012;78(5):1353–1360.CrossRefGoogle ScholarPubMed
18.Paul, S, Linardopoulou, EV, Billig, M, et al.Role of homologous recombination in adaptive diversification of extra-intestinal Escherichia coli. J Bacteriol 2012;195:231–242.Google Scholar